Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-06-27T07:11:53.533Z Has data issue: false hasContentIssue false

Uterine gene therapy and implantation

Published online by Cambridge University Press:  01 March 2000

A M SHARKEY
Affiliation:
Department of Obstetrics and Gynaecology, Level 2, Rosie Maternity Hospital, Robinson Way, Cambridge CB2 2SW, UK

Abstract

The endometrium undergoes cyclical changes under the influence of ovarian steroids, resulting in a tissue receptive to embryo implantation. These changes involve complex interactions between stromal cells, overlying epithelium, blood vessels and the embryo itself. For many women endometrial dysfunction is the source of considerable ill health, causing menstrual problems, pain and infertility. As the use of fertility control has become more widespread across the world, regular menstruation is the norm and abnormalities of menstruation have increased in consequence. Hormone treatments have had limited success in treating these longstanding problems, and new approaches to modulating endometrial functions such as menstruation and implantation (including contraceptives) are needed.

Type
Research Article
Copyright
© 2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)